Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the acute effect of recombinant human brain natriuretic peptide(rhBNP) on
pulmonary hypertension of acute exacerbations of chronic pulmonary disease. rhBNP was
administered as a continuous infusion for 24 hours , pulmonary artery pressure and other
hemodynamic parameters were monitored by Swan- Ganz catheter.